Physicochemical properties, binary and ternary phase diagrams of ketoprofen

被引:22
作者
Lu, YH [1 ]
Ching, CB [1 ]
机构
[1] Natl Univ Singapore, Dept Chem & Environm Engn, Singapore 117575, Singapore
关键词
antiinflammatory; racemic compound; crystallization; phase diagram; solubility;
D O I
10.1002/chir.20075
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Compared to simulated moving bed (SMB) chromatography, fractional crystallization is a simple and economical method for enantioseparation. Therefore, the coupling of SMB chromatography and fractional crystallization is suggested for enantioseparation of racemic compounds. In this work, a nonsteroidal antiinflammatory drug, ketoprofen (Kp), was chosen to be studied. Kp was verified as a racemic compound by FTIR, PXRD, and thermodynamic calculations. To derive the condition where pure (S)-Kp could be crystallized from a solution, which was previously enantiomerically enriched, the binary melting phase diagram and the ternary solubility phase diagram in the mixed solvent of ethanol and water over a temperature range of 15-30degreesC were obtained. From these phase diagrams the eutectic point was determined as 91.6% mole percent (S)-Kp from the binary phase diagram and 91% from the ternary phase diagram. The results may provide valuable experiment data for the possibility of coupling fractional crystallization with SMB for Kp separation. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:541 / 548
页数:8
相关论文
共 14 条
[1]   Phase diagram of EC-DMC binary system and enthalpic determination of its eutectic composition [J].
Ding, MS ;
Xu, K ;
Jow, TR .
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2000, 62 (01) :177-186
[2]   PREPARATIVE CHROMATOGRAPHIC-SEPARATION OF ENANTIOMERS [J].
FRANCOTTE, E ;
JUNKERBUCHHEIT, A .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 576 (01) :1-45
[3]  
Jacques J., 1981, Enantiomers, Racemates and Resolutions
[4]   CLINICAL PHARMACOKINETICS OF KETOPROFEN AND ITS ENANTIOMERS [J].
JAMALI, F ;
BROCKS, DR .
CLINICAL PHARMACOKINETICS, 1990, 19 (03) :197-217
[5]   Relationship between physical properties and crystal structures of chiral drugs [J].
Li, ZJ ;
Grant, DJW .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (10) :1073-1078
[6]   Binary and ternary phase diagrams of two enantiomers in solvent systems [J].
Lorenz, H ;
Seidel-Morgenstern, A .
THERMOCHIMICA ACTA, 2002, 382 (1-2) :129-142
[7]   Coupling of simulated moving bed chromatography and fractional crystallisation for efficient enantioseparation [J].
Lorenz, H ;
Sheehan, P ;
Seidel-Morgenstern, A .
JOURNAL OF CHROMATOGRAPHY A, 2001, 908 (1-2) :201-214
[8]  
Mullin J.W., 2001, CRYSTALLIZATION
[9]   CHIRALITY IN NEW DRUG DEVELOPMENT - CLINICAL PHARMACOKINETIC CONSIDERATIONS [J].
NATION, RL .
CLINICAL PHARMACOKINETICS, 1994, 27 (04) :249-255
[10]   Synthesis of chiral crystallization processes [J].
Schroer, JW ;
Wibowo, C ;
Ng, KM .
AICHE JOURNAL, 2001, 47 (02) :369-387